In gastric cancer, the expression of miR‐422a can help drive a metabolic shift from aerobic glycolysis to oxidative phosphorylation by decreasing pyruvate dehydrogenase kinase 2 (PDK2) and thereby modulate de novo lipogenesis.168. This evidence concerns the gene PDK2 and gastric cancer.